Astex Pharmaceuticals, Inc. (Nasdaq: ASTX) announced its plan to submit an Investigational New Drug or IND application to the Food ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE